Bearish MACD for Symmetry Medical (SMA)

Symmetry Medical (SMA) MACD indicator has entered into bearish territory with a reading of -0.0709. The Zacks #4 Rank (“Sell”) stock dipped more than 2% to $10.58 in morning trade. The Zacks Consensus Estimate on the company’s earnings for 2010 is currently pegged at 48 cents per share, which moved down a penny over the past 2 months.

SYMMETRY MEDICL (SMA): Free Stock Analysis Report
Zacks Investment Research

About Zacks Investment Research 1766 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.